Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Buch, Shama C ^a   Diergaarde, Brenda ^a   Nukui, Tomoko ^a   Day, Roger S ^a   Siegfried, Jill M ^a   Romkes, Marjorie ^a   Weissfeld, Joel L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Case control; Lung cancer; SNP

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL CYCLE CHECKPOINTS; DNA REPAIR; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC VARIATION; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84864766502     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20858     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. The impact of smoking on disease and the benefits of smoking reduction (Table 7.3). The Health Consequences of Smoking: A report of the Surgeon General [Atlanta, GA]: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, D.C.: For sale by the Supt. of Docs., U.S.G.P.O., 2004.
3. Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors. Clin Cancer Res 2009; 15: 5626-5645.
4. Villeneuve PJ, Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health 1994; 85: 385-388.
5. Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: Molecular profiles and therapeutic implications. Clin Cancer Res 2009; 15: 5646-5661.
6. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res 2005; 577: 275-283.
7. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 1996; 56: 2546-2549.
8. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-1174.
9. Hung RJ, Christiani DC, Risch A, et al. International Lung Cancer Consortium: Pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 2008; 17: 3081-3089.
10. Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005; 116: 768-773.
11. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res 2007; 13: 5974-5981.
12. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2773-2781.
13. Pritchard J, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 949-959.
14. Thomas DC, Witte JS. Point: Population stratification: A problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002; 11: 505-512.
15. Barrett J, Fry B, Maller J, Daly M. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
16. Friedlin B, Zheng G, Li Z, Gastwirth J. Trend tests for case-control studies of genetic markers: Power, sample size and robustness. Hum Hered 2002; 53: 146-152.
17. Kuo C-L, Feingold E. What's the best statistic for a simple test of genetic association in a case-control study? Genet Epidemiol 2010; 34: 246-253.
18. Oksenych V, Coin F. The long unwinding road: XPB and XPD helicases in damaged DNA opening. Cell Cycle 2010; 9: 90-96.
19. Wang SS, Gonzalez P, Yu K, et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS ONE 2010; 5: e8667.
20. Lindahl T, Barnes DE. Mammalian DNA ligases. Annu Rev Biochem 1992; 61: 251-281.
21. Shen H, Spitz MR, Qiao Y, Zheng Y, Hong WK, Wei Q. Polymorphism of DNA ligase I and risk of lung cancer-A case-control analysis. Lung Cancer 2002; 36: 243-247.
22. Michiels S, Danoy P, Dessen P, et al. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 2007; 28: 1731-1739.
23. Lee Y-CA, Morgenstern H, Greenland S, et al. A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers. Int J Cancer 2008; 122: 1630-1638.
24. Chang JS, Wrensch MR, Hansen HM, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 2008; 123: 2095-2104.
25. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 2010; 10: 293-301.
26. Fong PC, Boss DS, Yap TA, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. New Engl J Med 2009; 361: 123-134.
27. Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 2005; 114: 730-737.
28. Lockett KL, Hall MC, Xu J, et al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 6344-6348.
29. Wang X-G, Wang Z-Q, Tong W-M, Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Comun 2007; 354: 122-126.
30. Zhang X, Miao X, Liang G, et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005; 65: 722-726.
31. Choi JE, Park SH, Jeon H-S, et al. No association between haplotypes of three variants (codon 81, 284 and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 947-949.
32. Horton JK, Watson M, Stefanick DF, Shaughnessy DT, Taylor JA, Wilson SH. XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 2008; 18: 48-63.
33. Cote ML, Yoo W, Wenzlaff AS, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 2009; 30: 626-635.
34. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005; 97: 567-576.
35. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 359-365.
36. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis. Lung Cancer 2006; 54: 267-283.
37. Wang Y, Yang H, Li H, et al. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: A meta-analysis. Cancer Lett 2009; 285: 134-140.
38. Zheng H, Wang Z, Shi X, Wang Z. XRCC1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis. Lung Cancer 2009; 65: 268-273.
39. Vineis P, Manuguerra M, Kavvoura FK, et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009; 101: 24-36.
40. Gauderman W, Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. 2006; http://hydra.usc.edu/gxe/.
41. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.
42. Young RP, Hopkins RJ, Hay BA, et al. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 2009; 85: 515-524.